ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Microfluidics-Enabled Nanovesicle Delivers CD47/PD-L1 Antibodies to Enhance Antitumor Immunity and Reduce Immunotoxicity in Lung Adenocarcinoma.

Zhenwei Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.